Cancer research is in a great space now days thanks to all of the new advancements in the industry. Seattle Genetics, a Washington-based oncology company, is leading the way in cancer research thanks to its high-quality medications. These medications are known as antibody-drug conjugates, and they are able to attack cancer cells within the body. After attaching themselves to the cancer cells, the drug will inject its properties, which results in killing the cancer cells. All of this is achieved without ever harming any of the body’s good cells. Clay Siegal, M.D., Ph.D., is the head man in charge at Seattle Genetics, and he has helped to transcend cancer research.
If you’re not too familiar with cancer research, then you probably have never heard of this man. Dr. Siegall is one of the most well-known and well-trained professionals in this specific community. He has used his core principles to aggressively fight cancer. This includes rigorous research, drug development and scientific innovation. He is also a master of his craft. Dr. Siegall has a brilliant educational background thanks to having a Ph.D in Genetics from George Washington University. In addition to that, he has a B.S. in Zoology from the University of Maryland. As of today, Dr. Siegall is known to be a scientist, a doctor, an author and an entrepreneur. His plate is literally filled to the max, but saving lives is much more important than taking time off.
“I was always very interested in medicine and how technology is used to fight illnesses,” said Dr. Siegall. Cancer has touched most people in one way or another whether it’s directly or indirectly. Dr. Siegall’s father suffered with the disease for nearly five years. This disease lit a fire under Siegall, and he has never looked back. Though Dr. Siegall has been in the game for nearly four decades, his quest to eradicate cancer has never looked more promising than it currently does today.